BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Verily and Kyverna Collaborate to Advance Cell Therapy for Autoimmune Diseases

Verily, an Alphabet precision health technology company, and Kyverna Therapeutics ("Kyverna"), a clinical-stage cell therapy company engineering a new clas...

September 08, 2023 | News

Brii Biosciences Reports Phase 2 Results for BRII-179 in Hepatitis B Combo Treatment

The cohort level unblinded data from the study demonstrated that in the intent to treat analysis at Week 24 (end of treatment or EoT), 26.3% (15 pa...

September 07, 2023 | News

Gloria Biosciences' Zimberelimab Approved in China for Recurrent Cervical Cancer

Guangzhou Gloria Biosciences ("GloriaBio"), a commercial stage biopharmaceutical company focusing on the discovery, development and commercialization of bi...

September 07, 2023 | News

Biocon Biologics Expands Global Presence, Completes Viatris Biosimilars Integration in North America Ahead of Schedule.

To further strengthen its leadership position in the global biosimilars industry and provide complete end-to-end capabilities to patients and customers, Bi...

September 07, 2023 | News

Isotopia Issues a call to action to the radionuclide Therapy industry.

The Lu-177 radiopharmaceuticals sector stands at a critical juncture, necessitating urgent collaboration. Our shared duty as supply chain stewards has neve...

September 07, 2023 | News

"Advancing Precision Oncology: Dr. Jerome Boyd-Kirkup Discusses Breakthroughs in HMBD-001 Trials"

In this exclusive interview with Dr. Jerome Boyd-Kirkup, Chief Scientific Officer of Hummingbird Bioscience, BioPharma APAC delve into the recently i...

September 06, 2023 | News

Yourgene Health Launches MagBench Automated DNA Extraction Instrument and Kit for NIPT Workflows

Yourgene Health plc (“Yourgene”, AIM: YGEN), a leading international molecular diagnostics group, today launched the Yourgene® MagBenc...

September 06, 2023 | News

Genmab and Seagen Report TIVDAK® Success in Cervical Cancer Survival Trial

Phase 3 innovaTV 301 confirmatory trial met its primary endpoint of improved overall survival (OS) at predetermined, independent interim analysis ...

September 05, 2023 | News

Agilent and ACTRIS Partner to Accelerate Cell and Gene Therapy in Singapore

Agilent Technologies Inc. (NYSE: A) recently signed a Memorandum of Understanding (MOU) with the Advanced Cell Therapy and Research Institu...

September 05, 2023 | News

ABM Therapeutics Initiates Phase I Study of ABM-1310 in BRAF V600 Brain Tumors

ABM-1310, the company's proprietary clinical candidate developed as a next-generation BRAF inhibitor and demonstrated superior properties in pre-clinical a...

September 04, 2023 | News

Biocytogen Creates Divisions to Separate Preclinical Models and Antibody R&D

Biocytogen’s preclinical platforms include custom gene-editing services, generation of off-the-shelf humanized and/or immunodeficient animal and cell...

August 31, 2023 | News

Epigenic Therapeutics Raises $32M for Breakthrough Epigenome Medicine Development

This round of financing will support the preclinical development and early clinical validation of two leading programs, discovery of future pipelines, expa...

August 30, 2023 | News

BioSkryb Genomics Partners with Research Instruments: Bringing Single-Cell Tech to Singapore & Southeast Asia

BioSkryb Genomics, a company transforming single-cell analysis by enabling the most complete multiomic view of the cellular ecosystem, from discovery to di...

August 30, 2023 | News

Malaysian Genomics Unveils Strategic Advances in Biopharmaceuticals

Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, recorded a revenue of RM2.23 million for the 4th quarter en...

August 29, 2023 | News

Stay Connected